Lifebank Grants Stock Options to Chief Financial Officer
09 November 2010 - 11:03AM
Marketwired
Lifebank Corp. ("Lifebank" or the "Company") (TSX VENTURE: LBK)
announces that a total of 100,000 incentive stock options have been
granted to Jeff Charpentier, the Company's Chief Financial Officer
pursuant to the Company's Stock Option Plan. The options are
exercisable for a period of five (5) years at a price of $0.16 per
share.
About Lifebank
Started in 1996, Lifebank is a leading national company in the
biomedical field. Based at the British Columbia Institute of
Technology campus in Burnaby, Lifebank provides processing and
cryogenic (ultra low temperature) storage of umbilical cord blood
stem cells for families in Canada and world-wide. A full
description of the advantages and benefits of storing the stem
cells from an infant's umbilical cord can be found on the Company's
website at www.lifebank.com.
On January 21, 2004, Lifebank received official accreditation
from the international organization AABB and was the first
accredited cord blood stem cell bank in Canada. In February 2010,
celebrating another milestone in Cellular Therapy and Transplant
Medicine, Lifebank has achieved the globally recognized FACT
accreditation.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contacts: Lifebank Corp. F. Ernest Stacey President & CEO
604-738-2722 or Toll Free: 1-888-888-7836 604-738-2726 (FAX)
ernest@lifebank.com www.lifebank.com
Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From May 2024 to Jun 2024
Lifebank Corp. (TSXV:LBK)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Lifebank Corp. (TSX Venture Exchange): 0 recent articles
More Lifebank Corp. News Articles